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Edited by Varda RotterAbstract Klotho has recently emerged as a regulator of aging.
To investigate the role of Klotho in the regulation of cellular
senescence, we generated stable MRC-5 human primary ﬁbro-
blast cells knockdown for Klotho expression by RNAi. Downreg-
ulation of Klotho dramatically induces premature senescence
with a concomitant upregulation of p21. The upregulation of
p21 is associated with cell cycle arrest at G1/S boundary. Knock-
down of p53 in the Klotho attenuated MRC-5 cells restores nor-
mal growth and replicative potential. These results demonstrate
that Klotho normally regulates cellular senescence by repressing
the p53/p21 pathway. Our ﬁndings implicate Klotho as a regula-
tor of aging in primary human ﬁbroblasts.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Aging is a fundamental process, aﬀecting all organisms from
yeast to mammals. The aging process can be regulated by mul-
tiple genetic pathways that have emerged as conserved among
evolutionary distinct species. One of many proteins that have
been implicated in the regulation of aging is Klotho.
Overexpression of Klotho extends mouse lifespan by 20%
while loss of Klotho function (kl/kl/) results in the acceler-
ated onset of progeriod traits [1,2]. kl/kl/ mice manifest
infertility, arteriosclerosis, skin atrophy, osteoporosis, and
other age-associated inﬁrmities three to four weeks after birth
[2]. Soon thereafter, kl/kl/ mice exhibit growth retardation
and gradually become inactive; dying prematurely around
two month of age [2].
Mouse Klotho is expressed in the distal renal tubules and in
the choroid plexus of the brain; existing in both a membrane-
bound and secreted form [2–4]. Membrane bound Klotho is a
single-pass transmembrane protein containing an N-terminal
signal sequence, an extracellular domain containing repeated
sequences (KL1 and KL2), and a short intracellular domainAbbreviations: IGF-1, insulin growth factor-1; CDK, cyclin-dependent
kinase; b-gal, b-galactosidase; IRS1, insulin receptor substrate 1;
HDF, human dermal ﬁbroblasts
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doi:10.1016/j.febslet.2006.09.036[4]. Secreted Klotho, lacks the KL2 sequence, transmembrane
and intracellular domains, and arises as a consequence of alter-
native splicing [4]. Functionally, Klotho overexpression in
mice has been shown to attenuate the insulin/insulin growth
factor-1 (IGF-1) 1 signaling pathway [1]. It has been shown
that Klotho increases resistance to oxidative stress both
in vitro and in vivo [5]. Klotho also regulates calcium metab-
olism by hydrolyzing extracellular sugar residues on the tran-
sient receptor potential ion channel TRPV5, entrapping the
channel in the plasma membrane [6].
Human Klotho is mainly expressed in the kidney; it is also
detectable in small intestines, hippocampus, placenta and pros-
tate. With the secreted form being the predominant form of the
protein [3,4]. Reduced production of this protein has been ob-
served in patients with chronic renal failure. Klotho has also
been implicated in human aging. Single nucleotide polymor-
phisms in the human Klotho gene are associated with altered
lifespan, osteoporosis, stroke and altered risk for coronary
artery disease [7–12]. The molecular basis of these eﬀects is
yet to be determined.
Non-transformed animal cells have a ﬁnite proliferative
capacity in culture, known as the Hayﬂick limit, that results
in irreversible proliferative arrest named cellular senescence
[13]. Phenotypic changes of senescent cultured cells include
enlargement, ﬂattened morphology, expression of acidic b-
galactosidase (b-Gal) and a permanent cell cycle arrest at
G1 [14]. The pro-apoptotic protein p53 regulates the tran-
scription of genes involved in cell-cycle arrest and apoptosis
and is a well-characterized regulator of cellular senescence
[15]. Transient or irreversible p53-mediated cell cycle arrest
in the transition from the G1 to S phase of cell replication
is mediated by the transcriptional activation of the cyclin-
dependent kinase (CDK) inhibitors such as p16 and p21
[16]. As cells exhaust their replicative potential, increased
p53 activity activates CDK’s, triggering growth arrest and
senescence [17].
In this study, we have sought to determine if Klotho regu-
lates human cellular senescence and to elucidate the molecular
pathway of its function in human cells. We ﬁnd that reduction
of Klotho expression by RNAi induces premature senescence
of primary human ﬁbroblasts.2. Materials and methods
2.1. Cell culture
MRC-5 and WI-38 cells supplemented with fetal bovine serum
(FBS; 10% v/v), L-glutamine (2 mM), penicillin (100 U/ml), andblished by Elsevier B.V. All rights reserved.
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supplemented with FBS (10% v/v), L-glutamine (2 mM), penicillin
(100 U/ml), and streptomycin (100 lg/ml). Cells were cultured at
37 C in a humidiﬁed incubator containing 5% CO2 (g).2.2. b-Gal staining
Cells for b-Gal staining were plated in six well plates. One day
after plating, cells were washed in PBS, ﬁxed for 5 min in 2% formal-
dehyde/0.2% glutaraldehyde. Fixed cells were washed with PBS and
incubated at 37 C with senescence associated 6-Gal staining solution
(1 mg/ml of X-Gal, 40 mM citric acid, 5 mM potassium ferrocyanide,
5 mM potassium ferricyanide, 150 mM NaCl, 2 mM MgCl2, pH 6.0).
Staining was detected by light microscopy following an overnight incu-
bation.2.3. Plasmids
RNAi retroviral plasmids were constructed using the plasmid pSU-
PER.retro (OligoEngine, Seattle, WA). The RNAi sequences used
were: Klotho (1) 5 0 aagttacaaatagttctgaac 3 0 and Klotho (2) 5 0 aaggaa-
tatgacatacagtgc 3 0. The p53 RNAi was obtained from Dr. R. Agami
(Amsterdam, The Netherlands).Fig. 1. Klotho RNAi triggers senescence (A) Human lung ﬁbroblasts cells (M
with puromycin. Cells were then passage until they underwent senescence,
Similar results were obtained from three independent experiments. (B) Wh
examined by Western blot for expression of Klotho. Tubulin was used as a
MRC5 cells infected with pSUPER or Klotho RNAi. The photographs were
were counted in three random ﬁelds and the standard deviation is indicated2.4. Viral production
Viral stocks were obtained by co-transfecting 293T cells with the
pSUPER.retro, VSV-G and pCMVC3 using Fugene 6 (Roche Applied
Science) transfection reagent. Retroviruses were harvested 48 h post
transfection. Stable MRC-5 cells expressing RNAi were obtained by
viral infection performed in the presence of polybrene and selection
with puromycin. The third day after infection was designated day zero
in all of the experiments.
2.5. Lifespan assay
Proliferative lifespan was determined by growing cells continuously
until senescence. Every ﬁve days cells were assayed for cell number and
visual morphology and subsequently sub-cultured with exactly 3 · 105
cells. The number of population doublings (PDL) for each culture was
determined by the formula (logN  logN0)/log2, where N is the cell
number at each ﬁve day interval and N0 is the cell number at the time
of seeding (3 · 105).
2.6. Western blots
Cells were lysed in protein sample buﬀer, vortexed, boiled for
10 min, and centrifuged at 17000 · g for 5 min. Proteins concentra-
tions were determined by Bio-Rad DC protein assay kit (Bio-Rad).RC5) infected with pSUPER (Mock) or Klotho RNAi were selected
and the number of cumulative population doubling was determined.
ole cell lysates of each-infected population (processed as in (A)) were
loading control. (C) Senescence associated b-galactosidase staining in
taken at day 8 of lifespan. (D) Positive b-galactosidase cells (from B)
.
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protein) were separated by SDS–PAGE (4–15% gradient), and trans-
ferred onto nitrocellulose membranes and incubated for 1 h or over-
night at 4 C in blocking solution (5% low fat milk, 0.1% Tween 20
in PBS). Membranes were incubated for 1 h or overnight at 4 C with
primary antibodies, washed, and incubated with the appropriate horse-
radish peroxidase-conjugated secondary antibody. Primary antibodies
used were as follows: a-Klotho was a gift from Tokyo Research Lab-
oratories, Kyowa Hakko Co, Ltd., a-Ins-R, a-IGFl-R, a-p21, a-p53
and a-pl6 were from Santa Cruz Biotechnology. a-IRS1, a-pIRS1,
a-AKT, a-pAKT, aFOXO3 and a-pFOXO3 were from Cell Signaling
Technology. ECL reagent (Amersham Biosciences) was used for
chemiluminescent visualization.
2.7. Flow cytometry
Klotho RNAi cells and mock cells were harvested by trypsinization
on day 8 of lifespan. Cells were washed twice with ice-cold PBS, resus-
pended in cold PBS and ﬁxed by adding ethanol to a ﬁnal concentration
of 70% overnight at 4 C. Cell were washed in PBS and resuspended in
PBS. Cells were stained with 50 lMpropidium iodide (PI) for 30 min at
room temperature. The labeled cells were subsequently analyzed by
ﬂuorescence-activated cell sorting (FACS) analysis.3. Results
3.1. Downregulation of Klotho induces premature senescence of
human ﬁbroblasts
Little is known about the function of human Klotho pro-
tein in regulating cellular senescence. In order to assess theFig. 2. Klotho RNAi activates insulin/IGF-1 signaling and upregulates p2
Klotho RNAi and selected with puromycin were harvested. Cell lysates were
antibody, anti-IRSl antibody, anti-AKT antibody, anti-FOXO3 antibody, a
AKT (pAKT) and F0X03 (pFOXO3). Tubulin was used as a loading c
Asychronycous populations from day 8 of lifespan of MRC5 cells processed
staining. The percentage of cells in S, G0/G1 and G2/M phase are indicated. R
cell lysates of Klotho RNAi and pSUPER MRC5 cells processed as in Fig. 1A
p21 and p16. Tubulin as used as a loading control.role of Klotho in regulating cellular lifespan, MRC-5 pri-
mary human ﬁbroblasts were infected with either two diﬀer-
ent Klotho RNAi expression vectors targeting both
isoforms or pSUPER control vector and passaged until they
reached senescence. Downregulation of Klotho expression
by RNAi signiﬁcantly shortened replicative lifespan and
reduced the growth rate of MRC-5 cells compared with
mock-infected cells (Fig. 1A). Western blot analysis con-
ﬁrmed that Klotho protein expression in MRC-5 cells was
attenuated by Klotho RNAi compared to vector control
(see Fig. 1B for representative blot). Similar to the pheno-
type of senescent cells, Klotho RNAi cells were ﬂattened
and enlarged while mock-infected MRC-5 cells exhibited
normal morphology and growth. Utilizing senescence-associ-
ated b-Gal activity as a biomarker of cellular senescence we
found a 15-fold increase in b-Gal activity in Klotho RNAi
(1)-transduced cells compared to mock control and a sixfold
increase for Klotho RNAi (2) (Figs. 1D and 3D). By day
eight approximately 90% of the Klotho RNAi (1) cells
showed a positive b-Gal staining (Figs. 1D and 3D) and
only around 40% of the Klotho RNAi (2) cells were posi-
tive for b-Gal staining (Fig. 1D). Similar phenotypic
changes were also observed in WI-38 human ﬁbroblast cells
(Supplementary Figure). From these results we concluded
that Klotho is a regulator of cellular senescence in primary
human cells.1 in human cells. (A) MRC5 cells infected with pSUPER (Mock) or
immunoblotted with anti-insulin receptor antibody, anti-IGF1 receptor
nd antibodies speciﬁc for the phosphorylated forms of IRS1 (pIRS1),
ontrol. (B) Flow cytometry analysis of the cell cycle distribution.
as in Fig. 1A were labeled with PI. DNA content was measured by PI
esults are representative of three independent experiments. (C) Whole
on day 8 of lifespan were examined by Western blot for expression of
Fig. 3. p53 is required for Klotho RNAi mediated senescence. (A) MRC5 cells were infected with p53 RNAi, Klotho RNAi, p53 RNAi and Klotho
RNAi together or pSUPER (Mock). After selection with puromycin, cells were passage until one of the populations underwent senescence, and the
number of cumulative population doubling was determined. Similar results were obtained from three independent experiments. (B) Whole cell lysates
of each-infected population (processed as in (A)) were examined by Western blot for expression of Klotho and p53. Tubulin was used as a loading
control. (C) Senescence associated b-galactosidase staining in MRC5 cells processed as in (A). The photographs were taken at day 8 of lifespan. (D)
Positive b-galactosidase cells (from C) were counted in three random ﬁelds and the standard deviation is indicated.
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upregulates p21 in human cells
Klotho has been reported to inhibit the insulin/IGF-1 signal-
ing pathway in mouse [1]. To determine whether Klotho RNAi
aﬀects insulin signaling in primary ﬁbroblasts we examined the
expression level of various proteins in the insulin-signaling
pathway (Fig. 2A). In Klotho RNAi MRC-5 cells levels of
the insulin receptor (Ins-R) and insulin growth factor 1 recep-
tor are unaltered compared to control treated cells (Fig. 2A).
However, while the absolute level of insulin receptor substrate
1 (IRS1) is also unchanged, the level of phosphorylated IRS1 is
higher in MRC-5 cells treated with Klotho RNAi (Fig. 2A),
suggesting an upregulation of signaling at this early step in
the pathway. Examining the level of components downstream
of IRS1, revealed that while the levels of both AKT kinase and
the forkhead transcription factor FOXO3 are not changed by
Klotho RNAi, the levels of phosphorylated AKT and phos-
phorylated FOXO3 (the inactive cytoplasmic form) are higher
(Fig. 2A). Taken together these results suggest that loss of Klo-
tho activity in primary human cells results in the activation of
kinase signaling within the insulin pathway, ultimately leading
to increased phosphorylation of FOXO3.
Downregulation of FOXO3 in primary cultured human der-
mal ﬁbroblasts (HDFs) cells has been show to induce prema-
ture senescence by upregulating p21 in a p53 dependent
manner [18]. Given that Klotho RNAi cells show an increased
level of phosphorylated FOXO3 we examined the expression
of p21 and p16 by Western blot. Relative to control cells Klo-
tho RNAi infected cells have similar levels of p16 protein butelevated expression of p21 (Fig. 2B). In order to test whether
these cells were arrested at the G1/S boundary of the cell cycle,
we performed cell cycle analysis. FACS analysis of asynchro-
nous Klotho RNAi and control cells revealed that Klotho
RNAi results in a 23% decrease in S phase cell population
and a 29% increase in G0/G1 cells compared to control cells
(Fig. 2C). Thus Klotho RNAi cells are arrested at G1/S
boundary of the cell cycle. Since upregulation of p21 expres-
sion and cell cycle arrest are often a consequence of p53 acti-
vation, this result raises the possibility that loss of Klotho
function by RNAi results in p53 activation and senescence.
3.3. p53 is required for KLOTHO RNAi-induced cellular
senescence
It has been proposed that increasing of inactive F0X03 in
endothelial cells causes cellular damage, due to a downregula-
tion of MnSOD, leading to an increase of reactive oxygen spe-
cies (ROS) and p53-driven induction of p21 [19].
To further examine whether p53 played a role in the prema-
ture senescence of Klotho RNAi cells, we generated MRC-5
cell lines attenuated for both Klotho and p53 and assayed
for cellular lifespan (Fig. 3A). As before, knockdown of Klo-
tho alone induces premature senescence in MRC-5 cells, while
knockdown of p53 results in a similar growth rate and replica-
tive potential as control cells. However, downregulation of p53
by RNAi dramatically restored proliferative potential to Klo-
tho RNAi MRC-5 cells. Western blot analysis demonstrates a
dramatic loss of p53 protein in both p53 and p53/Klotho
RNAi cells (Fig. 3B) and a reduction in Klotho expression
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cally, Klotho/p53 RNAi cells appear similar to those infected
with p53 RNAi or vector alone, as no enlarged or ﬂattened
cells indicative of senescence phenotype were observed
(Fig. 3C), in contrast to what was seen with Klotho RNAi
treatment. Conﬁrming the ability of p53 attenuation to restore
replicative potential of Klotho RNAi cells, staining for b-Gal
shows approximately the same number of positive cells in
the double knockdown compared to the vector control or
p53 RNAi cells (Fig. 3D). Therefore, downregulation of p53
is suﬃcient to reverse Klotho RNAi-mediated premature
senescence in MRC-5 cells, suggesting that Klotho induces
senescence by a p53 dependent pathway, which presumably
is activated by forkhead proteins.4. Discussion
In this study, we demonstrate that human Klotho regulates
the replicative lifespan of primary human ﬁbroblast cells. First,
we showed that loss of Klotho activity by RNAi results in a
dramatic premature senescence phenotype in MRC-5 primary
human ﬁbroblast cells, resulting in both diminished replicative
capacity and early onset of senescence morphology. Since Klo-
tho aﬀects lifespan at the organism level in mouse and it aﬀects
in vitro lifespan of primary human ﬁbroblasts, the mechanism
of longevity mediated by Klotho may be conserved from
mouse to humans. Second, this early senescence is fully depen-
dent upon the cell cycle regulatory factor p53 and results in the
upregulation of a downstream p53-dependent CDK p21. Klo-
tho may have the ability to control apoptosis and senescence
by regulating p53 activity by a mechanism yet to be identiﬁed
(Fig. 4). This may explain, how Klotho modulates the ageing
process in higher organisms. Interestingly, kl/kl/ mice reca-
pitulate many aspects of the p53 mutant mice created by Tyner
et al. with one mutant p53 allele and one wild-type allele.Fig. 4. Proposed model for Klotho mode of action in senescence.
Klotho has an eﬀect on two major pathways involved in the regulation
of aging and senescence: the p53/p21 pathway and the insulin/IGF-1
pathway. Downregulation of Klotho promotes p53 activation by a
mechanism yet to be identiﬁed (question mark) leading to the
expression of p21 and the onset of senescence. Klotho downregulation
also activates the insulin/IGF-1 pathway starting at the IRS-1 levels,
ultimately leading to FOXO3 inactivation.These mice display early onset of phenotypes associated with
aging, including osteoporosis, reduced body weight and gener-
alized organ atrophy [20].
We also found that knockdown of Klotho function by
RNAi in MRC-5 cells results in increased phosphorylation
of IRS1, AKT, and the downstream forkhead transcription
factor FOXO3, suggesting that a normal function of Klotho
may be to inhibit insulin pathway signaling in human cells
(Fig. 4). In concordance with our ﬁndings in primary human
ﬁbroblasts, previous studies using primary human endothelial
cells showed that inhibition of insulin/IGF-1 signaling by con-
stitutive activation of AKT kinase results in premature senes-
cence and p21 dependent mechanism [19]. There is evidence for
F0X03 being a mediator of cellular senescence in HDFs via
p53/p21 upregulation [18].
Since Klotho exists in both a membrane and secreted forms,
it is possible that Klotho could act at the level of the insulin
receptor, either by preventing insulin binding, or by inhibiting
downstream signaling by protein–protein interactions within
the cell. For example, in its secreted form, Klotho could bind
and activate an unknown cell surface receptor that in turn
could associate with and inhibit signaling via the insulin recep-
tor in its insulin bound state.
In conclusion, our study shows that Klotho regulates the cel-
lular lifespan of human cells by repressing p53 and negatively
regulating p21 protein levels and this may be associated with
increased signaling through the insulin/IGF-1 pathway. This
which Klotho regulates cell proliferation and senescence is
likely to be multi-factorial. Since Klotho RNAi can trigger
premature senescence in normal human ﬁbroblasts, this path-
way may provide new insights into possible interventions in
aging and aging-associated diseases in humans.
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